Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOX1 | Q9Y5S8 | 8/20 | 0.38 |
| ▸ | GAA | P10253 | 8/20 | 0.37 |
| ▸ | MAPT | P10636 | 7/20 | 0.37 |
| ▸ | MEN1 | O00255 | 5/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.37 |
| ▸ | SNCA | P37840 | 2/20 | 0.37 |
| ▸ | CYBB | P04839 | 1/20 | 0.37 |
| ▸ | APP | P05067 | 1/20 | 0.37 |
| ▸ | NOX3 | Q9HBY0 | 1/20 | 0.37 |
| ▸ | NOX4 | Q9NPH5 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 4/20 | 0.36 |
| ▸ | NPC1 | O15118 | 4/20 | 0.36 |
| ▸ | RAB9A | P51151 | 4/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.36 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.36 |
| ▸ | GFER | P55789 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL436040 | 1.00 | NOX1 (0.38) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL436033 | 0.89 | NOX1 (0.41) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL563959 | 0.84 | GAA (0.42) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL433397 | 0.79 | MAPT (0.41) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL433232 | 0.77 | NOX1 (0.42) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL10370002 | 0.76 | GAA (0.48) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL434952 | 0.74 | SNCA (0.48) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL435356 | 0.74 | NOX1 (0.35) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL434961 | 0.74 | NOX1 (0.46) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL434466 | 0.74 | MAPT (0.46) | NOX1GAAMAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3753481-B1 | TRANSIENT DECAY AMPEROMETRY DEVICE | ASCENSIA DIABETES CARE HOLDINGS AG (CH) | 2024-07-17 | — | — | EP | disclosed |
| EP-2535703-B1 | Multi-electrode biosensor system | ASCENSIA DIABETES CARE HOLDINGS AG (CH) | 2021-11-03 | — | — | EP | disclosed |
| US-11091790-B2 | Determining analyte concentration from variant concentration distribution in measurable species | ASCENSIA DIABETES CARE HOLDINGS AG (CH) | 2021-08-17 | — | — | US | disclosed |
| EP-3369825-B1 | POROUS PARTICLE REAGENT COMPOSITIONS AND DEVICES FOR BIOSENSORS | ASCENSIA DIABETES CARE HOLDINGS AG (CH) | 2021-07-28 | — | — | EP | disclosed |
| US-10989683-B2 | Identifying ionizable species with voltammetric duty cycles | ASCENSIA DIABETES CARE HOLDINGS AG (CH) | 2021-04-27 | — | — | US | disclosed |
| EP-2499483-B1 | Method and biosensor for assessing the volume of a blood sample | ASCENSIA DIABETES CARE HOLDINGS AG (CH) | 2021-03-17 | — | — | EP | disclosed |
| US-10947328-B2 | Polymer comprising a plurality of phenothiazine groups and methods of making the same | ASCENSIA DIABETES CARE HOLDINGS AG (CH) | 2021-03-16 | — | — | US | disclosed |
| US-10895550-B2 | Multi-region and potential test sensors, methods, and systems | ASCENSIA DIABETES CARE HOLDINGS AG (CH) | 2021-01-19 | — | — | US | disclosed |
| EP-3753481-A1 | TRANSIENT DECAY AMPEROMETRY | Ascensia Diabetes Care Holdings AG (CH) | 2020-12-23 | — | — | EP | disclosed |
| EP-3543348-B1 | BIOSENSOR SYSTEM HAVING ENHANCED STABILITY AND HEMATOCRIT PERFORMANCE | ASCENSIA DIABETES CARE HOLDINGS AG (CH) | 2020-11-18 | — | — | EP | disclosed |
| WO-2010006253-A1 | SYSTEMS AND METHODS INCLUDING AMPEROMETRIC AND VOLTAMMETRIC DUTY CYCLES | BAYER HEALTHCARE LLC (US) | 2010-01-14 | — | — | WO | disclosed |
| EP-2089531-A1 | BIOSENSOR SYSTEM HAVING ENHANCED STABILITY AND HEMATOCRIT PERFORMANCE | Bayer Healthcare, LLC (US) | 2009-08-19 | — | — | EP | disclosed |
| EP-2083674-A2 | TRANSIENT DECAY AMPEROMETRY | Bayer Healthcare, LLC (US) | 2009-08-05 | — | — | EP | disclosed |
| US-20090178936-A1 | Porous Particle Reagent Compositions, Devices, and Methods for Biosensors | BAYER HEALTHCARE LLC (US) | 2009-07-16 | — | — | US | disclosed |
| WO-2009076402-A1 | POROUS PARTICLE REAGENT COMPOSITIONS, DEVICES, AND METHODS FOR BIOSENSORS | BAYER HEALTHCARE LLC (US) | 2009-06-18 | — | — | WO | disclosed |
| WO-2009042631-A2 | MULTI-ELECTRODE TEST SENSORS | BAYER HEALTHCARE LLC (US) | 2009-04-02 | — | — | WO | disclosed |
| US-20090068754-A1 | Transient Decay Amperometry | BAYER HEALTHCARE LLC (US) | 2009-03-12 | — | — | US | disclosed |
| US-20080156662-A1 | electrochemical sensor strips; By reducing the amount of mediator and/or enzyme used on the sensor strip, the long-term stability of the reagent composition may be increased in relation to conventional biosensors and reagent compositions | BAYER HEALTHCARE LLC (US) | 2008-07-03 | — | — | US | disclosed |
| WO-2008051742-A2 | TRANSIENT DECAY AMPEROMETRY | BAYER HEALTHCARE LLC (US) | 2008-05-02 | — | — | WO | disclosed |
| WO-2008036516-A1 | BIOSENSOR SYSTEM HAVING ENHANCED STABILITY AND HEMATOCRIT PERFORMANCE | BAYER HEALTHCARE LLC (US) | 2008-03-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10947328-B2 | Polymer comprising a plurality of phenothiazine groups and methods of making the same | PAH, TYK2, PNMT | NOX1 2861/4885GAA 380/4885MAPT 178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.